Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis
Yuqing Lou(Shanghai Jiao Tong University), Baohui Han(Shanghai Jiao Tong University)
Cited by 22
Related Papers
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2017|380
Anisotropy and Corotation of Galactic Cosmic Rays
|Science|2006|245
First Detection of Photons with Energy beyond 100 TeV from an Astrophysical Source
|Physical Review Letters|2019|207
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110